The epidemiological and economic burden of diabetes and Health Policy in different health care systems
The series was funded by an unrestricted educational grant from Novo Nordisk. As chronic a disease, diabetes is increasingly recognised to be a major contributor to the global burden of disease in both rich and poor countries. An investigation of the impact of, and response of national health health care systems to, diabetes is therefore appropriately in the spotlight. This special issue is a collection of papers that consider the epidemiological and economic burden and health policy options across a range of countries and illustrates the variety and complexity of the problems posed by this growing epidemic as well as some of the more innovative national responses and lessons learned.
Dr Panos Kanavos and Ms Alessandra Ferrario, London School of Economics and Political Science, United Kingdom